Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. DHASOLONE TABLET 5 MG [SIN04207P]

DHASOLONE TABLET 5 MG [SIN04207P]

Active ingredients: DHASOLONE TABLET 5 MG

Last updated 26 October 2025

Product Info

DHASOLONE TABLET 5 MG

[SIN04207P]

Product information

Active Ingredient and Strength

PREDNISOLONE BASE MICRONIZED - 5 MG

Dosage Form

TABLET

Manufacturer and Country

PT ACTAVIS INDONESIA - INDONESIA REP OF

Registration Number

SIN04207P

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

H02AB06

INDICATIONS:
For the suppression of inflammatory and allergic disorders and for the treatment of conditions for which corticosteroid therapy is indicated except in adrenal-deficiency states.

RECOMMENDED DOSES:
Orally administered:
Dosage requirements are variable and must be individualized on the basis of the disease under treatment and the response of the patient.
Adults : 5–60 mg daily in divided doses or as a single daily or double dose on alternate days.
In long term therapy, dosage should be maintained at not more than 7 mg daily whenever possible.
Children: As directed by physician.
For short term treatment of not more than 2 weeks, as it may lead to growth retardation in children.

CONTRA-INDICATIONS:
Patients with active or doubtfully quiescent tuberculosis. In the presence of acute infections, including herpes zoster and herpes simplex, ulceration of the eye. Patients with peptic ulcer, osteoporosis, pyschoses or severe psychoneuroses.